Sign in
4

Changes in Ownership

Zentalis Pharmaceuticals, Inc. Filed Acc 0001628280-26-064317

Chief Medical Officer acquired 9,727 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bruns Ingmar · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-30 Grant or award : show line 1 in the form +9,727 $2.18 $21,205 43,059 D
Loading xslF345X06/wk-form4_1790889591.xml…